Filing Details
- Accession Number:
- 0001225208-14-013102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-15 18:17:23
- Reporting Period:
- 2014-05-12
- Filing Date:
- 2014-05-15
- Accepted Time:
- 2014-05-15 18:17:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559381 | J. William Regan | 5600 Blazer Parkway Suite 200 Dublin OH 43017 | Svp-Global Reg Affairs&Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-12 | 4,400 | $1.43 | 9,400 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-05-12 | 500 | $1.43 | 9,900 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-05-12 | 100 | $1.43 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |